Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
American WellAMWL -4.76%50 Net Cash per Share is $5.32 as of Jun. 2026. GuruFocus rates AMWL with a GF Score™ of 50/100 and a GF Value™ of $6.37 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 136 Healthcare Providers & Services companies, American Well ranks better than 77.94% on this metric.
The historical rank and industry rank for American Well's Net Cash per Share or its related term are showing as below:
AMWL'
s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.73 Med: 1.81 Max: 7.33
Current: 2.39
During the past 8 years, the highest Price-to-Net-Cash Ratio of American Well was 7.33. The lowest was 0.73. And the median was 1.81.
AMWL's Price-to-Net-Cash is ranked better than 77.94% of 136
companies
in the Healthcare Providers & Services industry
Industry Median: 7.73
vs AMWL: 2.39
American Well (NYSE:AMWL) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
American Well Net Cash per Share Related Terms
American Well Net Cash per Share Historical Data
* Premium members only.
The historical data trend for American Well's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMWL vs SPOK, SY, LFMD: Net Cash per Share Comparison
For the Health Information Services subindustry, American Well's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Well Price-to-Net-Cash vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, American Well's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where American Well's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
American Well's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Well (AMWL) has a Net Cash per Share of $5.32 as of Jun. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on American Well and its competitors. According to the industry distribution chart, American Well ranks #30 out of 136 companies in the Healthcare Providers & Services industry, placing it in the top 22.1%.
Is American Well's Net Cash per Share too high?
American Well's current Net Cash per Share is $5.32. The Healthcare Providers & Services industry median Net Cash per Share is 7.73. American Well's value of $5.32 is 31.2% below this industry median. Based on the distribution chart, American Well ranks #30 out of 136 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, American Well has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Well's Net Cash per Share compare to SPOK and SY?
According to the Healthcare Providers & Services industry distribution chart, American Well ranks #30 out of 136 companies for Net Cash per Share. This places American Well in the top 22% of its industry — outperforming the majority of peers. The industry median Net Cash per Share is 7.73. American Well's value of $5.32 is 31.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Healthcare Providers & Services company?
The median Net Cash per Share among Healthcare Providers & Services companies is 7.73, based on 136 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Well's current Net Cash per Share of $5.32 is 31.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on American Well and its competitors. For the Healthcare Providers & Services industry, the median Net Cash per Share is 7.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Well's current Net Cash per Share is $5.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Well stock overvalued right now?
Based on GuruFocus' analysis, American Well (AMWL) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.37, compared to a current price of $12.71 — trading 99.5% above its estimated fair value. The current Net Cash per Share is $5.32 and 31.2% below the Healthcare Providers & Services industry median of 7.73. American Well's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For American Well (AMWL), the current Net Cash per Share is $5.32 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is American Well (AMWL) Overvalued in 2026?
Based on GuruFocus' analysis, American Well stock appears to be overvalued.
The current stock price of $12.71 is trading 99.5% above its estimated GF Value™ of $6.37.
GuruFocus considers American Well to be Significantly Overvalued.
Key valuation signals for AMWL:
Net Cash per Share: $5.32
GF Value™: $6.37 vs. price of $12.71 (99.5% above fair value)
Industry Position: 31.2% below the Healthcare Providers & Services median (#30 of 136)
No single metric tells the full story. See the AMWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
50GF Score
Get the complete analysis for AMWL
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMWL has been successfully added to your 
